Literature DB >> 28060997

Effect of hypercholesterolaemia on myocardial function, ischaemia-reperfusion injury and cardioprotection by preconditioning, postconditioning and remote conditioning.

Ioanna Andreadou1, Efstathios K Iliodromitis2, Antigone Lazou3, Anikó Görbe4,5,6, Zoltán Giricz4,5, Rainer Schulz6,7, Péter Ferdinandy4,5,6.   

Abstract

Hypercholesterolaemia is considered to be a principle risk factor for cardiovascular disease, having direct negative effects on the myocardium itself, in addition to the development of atherosclerosis. Since hypercholesterolaemia affects the global cardiac gene expression profile, among many other factors, it results in increased myocardial oxidative stress, mitochondrial dysfunction and inflammation triggered apoptosis, all of which may account for myocardial dysfunction and increased susceptibility of the myocardium to infarction. In addition, numerous experimental and clinical studies have revealed that hyperlcholesterolaemia may interfere with the cardioprotective potential of conditioning mechanisms. Although not fully elucidated, the underlying mechanisms for the lost cardioprotection in hypercholesterolaemic animals have been reported to involve dysregulation of the endothelial NOS-cGMP, reperfusion injury salvage kinase, peroxynitrite-MMP2 signalling pathways, modulation of ATP-sensitive potassium channels and apoptotic pathways. In this review article, we summarize the current knowledge on the effect of hypercholesterolaemia on the non-ischaemic and ischaemic heart as well as on the cardioprotection induced by drugs or ischaemic preconditioning, postconditioning and remote conditioning. Future perspectives concerning the mechanisms and the design of preclinical and clinical trials are highlighted. LINKED ARTICLES: This article is part of a themed section on Redox Biology and Oxidative Stress in Health and Disease. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v174.12/issuetoc.
© 2017 The British Pharmacological Society.

Entities:  

Mesh:

Year:  2017        PMID: 28060997      PMCID: PMC5446572          DOI: 10.1111/bph.13704

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  121 in total

1.  Blocking the mitochondrial permeability transition pore with cyclosporine-A can restore cardioprotection of ischemic postconditioning in hypercholesterolemic rat heart.

Authors:  N Wu; W-N Li; W-Q Shu; Y Lv; D-L Jia
Journal:  Eur Rev Med Pharmacol Sci       Date:  2015       Impact factor: 3.507

2.  Hypercholesterolemia abrogates the protective effect of ischemic postconditioning by induction of apoptosis and impairment of activation of reperfusion injury salvage kinase pathway.

Authors:  Nan Wu; Xiaowen Zhang; Pengyu Jia; Dalin Jia
Journal:  Biochem Biophys Res Commun       Date:  2015-01-28       Impact factor: 3.575

3.  Hyperlipidemia induced by high cholesterol diet inhibits heat shock response in rat hearts.

Authors:  Tamás Csont; Gábor Balogh; Csaba Csonka; Imre Boros; Ibolya Horváth; László Vigh; Péter Ferdinandy
Journal:  Biochem Biophys Res Commun       Date:  2002-02-08       Impact factor: 3.575

4.  Hypercholesterolemia abrogates late preconditioning via a tetrahydrobiopterin-dependent mechanism in conscious rabbits.

Authors:  Xian-Liang Tang; Hitoshi Takano; Yu-Ting Xuan; Hiroshi Sato; Eitaro Kodani; Buddhadeb Dawn; Yanqing Zhu; Gregg Shirk; Wen-Jian Wu; Roberto Bolli
Journal:  Circulation       Date:  2005-09-26       Impact factor: 29.690

Review 5.  Renin-angiotensin system at the crossroad of hypertension and hypercholesterolemia.

Authors:  C Borghi; R Urso; A F Cicero
Journal:  Nutr Metab Cardiovasc Dis       Date:  2016-08-06       Impact factor: 4.222

6.  Statin and resveratrol in combination induces cardioprotection against myocardial infarction in hypercholesterolemic rat.

Authors:  Suresh Varma Penumathsa; Mahesh Thirunavukkarasu; Srikanth Koneru; Bela Juhasz; Lijun Zhan; Rima Pant; Venugopal P Menon; Hajime Otani; Nilanjana Maulik
Journal:  J Mol Cell Cardiol       Date:  2006-12-26       Impact factor: 5.000

7.  The effect of acute hypercholesterolemia on myocardial infarct size and the no-reflow phenomenon during coronary occlusion-reperfusion.

Authors:  P Golino; P R Maroko; T E Carew
Journal:  Circulation       Date:  1987-01       Impact factor: 29.690

Review 8.  Statins and cardioprotection--more than just lipid lowering?

Authors:  Andrew Ludman; Vinod Venugopal; Derek M Yellon; Derek J Hausenloy
Journal:  Pharmacol Ther       Date:  2009-01-23       Impact factor: 12.310

Review 9.  NADPH oxidases in vascular pathology.

Authors:  Anna Konior; Agata Schramm; Marta Czesnikiewicz-Guzik; Tomasz J Guzik
Journal:  Antioxid Redox Signal       Date:  2013-11-01       Impact factor: 8.401

Review 10.  9th Hatter Biannual Meeting: position document on ischaemia/reperfusion injury, conditioning and the ten commandments of cardioprotection.

Authors:  R M Bell; H E Bøtker; R D Carr; S M Davidson; J M Downey; D P Dutka; G Heusch; B Ibanez; R Macallister; C Stoppe; M Ovize; A Redington; J M Walker; D M Yellon
Journal:  Basic Res Cardiol       Date:  2016-05-10       Impact factor: 17.165

View more
  30 in total

Review 1.  Current Modalities and Mechanisms Underlying Cardioprotection by Ischemic Conditioning.

Authors:  John H Rosenberg; John H Werner; Michael J Moulton; Devendra K Agrawal
Journal:  J Cardiovasc Transl Res       Date:  2018-05-24       Impact factor: 4.132

Review 2.  Effect of hypercholesterolaemia on myocardial function, ischaemia-reperfusion injury and cardioprotection by preconditioning, postconditioning and remote conditioning.

Authors:  Ioanna Andreadou; Efstathios K Iliodromitis; Antigone Lazou; Anikó Görbe; Zoltán Giricz; Rainer Schulz; Péter Ferdinandy
Journal:  Br J Pharmacol       Date:  2017-02-08       Impact factor: 8.739

3.  Pharmacology of oxidative stress: translational opportunities.

Authors:  Andreas Daiber; Fabio Di Lisa; Péter Ferdinandy
Journal:  Br J Pharmacol       Date:  2017-06       Impact factor: 8.739

Review 4.  The impact of dyslipidemia and oxidative stress on vasoactive mediators in patients with renal dysfunction.

Authors:  Maryam Jabarpour; Nadereh Rashtchizadeh; Hassan Argani; Amir Ghorbanihaghjo; Masoumeh Ranjbarzadhag; Davoud Sanajou; Fatemeh Panah; Amirhesam Alirezaei
Journal:  Int Urol Nephrol       Date:  2019-10-22       Impact factor: 2.370

Review 5.  Hyperlipidaemia and cardioprotection: Animal models for translational studies.

Authors:  Ioanna Andreadou; Rainer Schulz; Lina Badimon; Adriana Adameová; Petra Kleinbongard; Sandrine Lecour; Panagiota-Efstathia Nikolaou; Ines Falcão-Pires; Gemma Vilahur; Nicholas Woudberg; Gerd Heusch; Péter Ferdinandy
Journal:  Br J Pharmacol       Date:  2020-01-17       Impact factor: 8.739

6.  Luteolin alleviates cardiac ischemia/reperfusion injury in the hypercholesterolemic rat via activating Akt/Nrf2 signaling.

Authors:  Jin-Ting Yang; Jue Wang; Xin-Ru Zhou; Chi Xiao; Yang-Yun Lou; Li-Hui Tang; Feng-Jiang Zhang; Ling-Bo Qian
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-04-18       Impact factor: 3.000

Review 7.  Role of Erythropoiesis-Stimulating Agents in Cardiovascular Protection in CKD Patients: Reappraisal of Their Impact and Mechanisms.

Authors:  Tetsuji Miura; Tatsuya Sato; Toshiyuki Yano; Akira Takaguri; Takayuki Miki; Noritsugu Tohse; Keitaro Nishizawa
Journal:  Cardiovasc Drugs Ther       Date:  2022-02-12       Impact factor: 3.727

Review 8.  Potential Role of Tocotrienols on Non-Communicable Diseases: A Review of Current Evidence.

Authors:  Sok Kuan Wong; Yusof Kamisah; Norazlina Mohamed; Norliza Muhammad; Norliana Masbah; Nur Azlina Mohd Fahami; Isa Naina Mohamed; Ahmad Nazun Shuid; Qodriyah Mohd Saad; Azman Abdullah; Nur-Vaizura Mohamad; Nurul' Izzah Ibrahim; Kok-Lun Pang; Yoke Yue Chow; Benjamin Ka Seng Thong; Shaanthana Subramaniam; Chin Yi Chan; Soelaiman Ima-Nirwana; And Kok-Yong Chin
Journal:  Nutrients       Date:  2020-01-19       Impact factor: 5.717

9.  ω-3 Polyunsaturated Fatty Acid Postconditioning Protects the Isolated Perfused Rat Heart from Ischemia-Reperfusion Injury.

Authors:  Fu-Wei Zhang; Jian Tong; Yu-Sheng Yan; Qun-Qing Chen; Xiao-Ping Zhao
Journal:  Cardiorenal Med       Date:  2018-04-11       Impact factor: 2.041

Review 10.  Bladder Hyperactivity Induced by Oxidative Stress and Bladder Ischemia: A Review of Treatment Strategies with Antioxidants.

Authors:  Yi-Hsuan Wu; Kuang-Shun Chueh; Shu-Mien Chuang; Cheng-Yu Long; Jian-He Lu; Yung-Shun Juan
Journal:  Int J Mol Sci       Date:  2021-06-02       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.